- Nachrichtendetail
-
02.05.2024 08:11:34 - dpa-AFX: *AZN : CALQUENCE COMBINATION REGIMEN SHOWS PFS IMPROVEMENT IN FIRST-LINE MANTLE CELL LYMPHOMA IN PHASE III TRIAL
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
ASTRAZENECA PLC DL-,25 | 886455 | Frankfurt | 141,050 | 17.05.24 16:25:38 | -0,450 | -0,32% | 0,000 | 0,000 | 140,900 | 141,050 |
